Inventor · disambiguated record
Prasad V. Chaturvedula
Also filed as: CHATURVEDULA PRASAD · CHATURVEDULA PRASAD V · CHATURVEDULA PRASAD VENKATA CH
30 granted patents·4 pending applications·3,162 citations·filing 1994–2022
97Inventor score
Files withBRISTOL MYERS SQUIBB CO15SANOFI SA5VERTEX PHARMA4CHATURVEDULA PRASAD V2SPECTRUM PHARMACEUTICALS INC2
Top patents by PatentIndex Score
34 records- 0199US5663312AOligonucleotide dimers with amide linkages replacing phosphodiester linkagesSANOFI SA·Filed 1994·Granted Sep 2, 1997·1.3k cites·2 claims
- 0298US5677439AOligonucleotide analogues containing phosphate diester linkage substitutes, compositions thereof, and precursor dinucleotide analoguesSANOFI SA·Filed 1995·Granted Oct 14, 1997·1.2k cites·58 claims
- 0396US5703129A5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein productionBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Dec 30, 1997·186 cites·9 claims
- 0491US7384930B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 10, 2008·21 cites·13 claims
- 0590US7384931B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 10, 2008·10 cites·6 claims
- 0690US5552400AFused-bicyclic lactams as interleukin-1β converting enzyme inhibitorsSTERLING WINTHROP INC·Filed 1994·Granted Sep 3, 1996·70 cites·10 claims
- 0789US8481546B2CGRP receptor antagonistCHATURVEDULA PRASAD V·Filed 2011·Granted Jul 9, 2013·17 cites·3 claims
- 0889US7754732B2Spirocyclic anti-migraine compoundsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jul 13, 2010·13 cites·32 claims
- 0988US7834007B2CGRP antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 16, 2010·9 cites·10 claims
- 1088US7314883B2Anti-migraine treatmentsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jan 1, 2008·12 cites·36 claims
- 1187US7842808B2Anti-migraine spirocyclesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Nov 30, 2010·13 cites·36 claims
- 1287US5585357AHeteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitorsSANOFI WINTHROP INC·Filed 1996·Granted Dec 17, 1996·69 cites·24 claims
- 1383US6967196B1Sulfonamide compounds and uses thereofMERCK & CO INC·Filed 2000·Granted Nov 22, 2005·24 cites·4 claims
- 1482US7449586B2Processes for the preparation of CGRP-receptor antagonists and intermediates thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Nov 11, 2008·4 cites·1 claims
- 1581US5670494AN-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitorsSANOFT·Filed 1995·Granted Sep 23, 1997·49 cites·2 claims
- 1680US7569578B2Heterocyclic anti-migraine agentsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Aug 4, 2009·14 cites·31 claims
- 1779US7220862B2Calcitonin gene related peptide receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 22, 2007·11 cites·36 claims
- 1876US5639745AFused-bicyclic lactams as interleukin-1β converting enzyme inhibitorsSANOFI SA·Filed 1995·Granted Jun 17, 1997·37 cites·33 claims
- 1972US6162800AN-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitorsVERTEX PHARMA·Filed 1997·Granted Dec 19, 2000·25 cites·7 claims
- 2071US7470680B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Dec 30, 2008·1 cites·9 claims
- 2171US2023106731A1Inhibitors of mutant family tyrosine-kinasesSPECTRUM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2270US7049323B2Amidoheterocycles as modulators of the melanocortin-4 receptorBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 23, 2006·2 cites·10 claims
- 2369US6407080B2N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitorsVERTEX PHARMA·Filed 2000·Granted Jun 18, 2002·3 cites·5 claims
- 2469US5677283Aα-heteroaryloxymethyl ketones as interleukin - 1 β converting enzyme inhibitorsSANOFI SA·Filed 1996·Granted Oct 14, 1997·26 cites·3 claims
- 2567US5985838APeptide analogs as irreversible interleukin-1β protease inhibitorsVERTEX PHARMA·Filed 1996·Granted Nov 16, 1999·8 cites·11 claims
- 2665US6432944B1Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivativesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Aug 13, 2002·2 cites·9 claims
- 2765US5892024ABifunctional nucleosides, oligomers thereof, and methods of making and using the sameSANOFI SA·Filed 1997·Granted Apr 6, 1999·21 cites·3 claims
- 2864US8592423B2Inhibitors of PDE10CHATURVEDULA PRASAD V·Filed 2012·Granted Nov 26, 2013·1 cites·10 claims
- 2964US6576614B1Peptide analogs as irreversible interleukin-1β protease inhibitorsVERTEX PHARMA·Filed 1999·Granted Jun 10, 2003·7 cites·9 claims
- 3058US7544680B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 9, 2009·0 cites·9 claims
- 3154US2021353627A1Novel quinazoline egfr inhibitorsSPECTRUM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3251US7470679B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Dec 30, 2008·0 cites·10 claims
- 3349US2004009923A1Peptide analogs as irreversible interleukin-1beta protease inhibitorsFiled 2003·Application pending·0 cites
- 3447US2004063735A1Calcitonin gene related peptide receptor antagonistsFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →